ArticleBreast cancer research and treatment2026

Adjuvant capecitabine in women with triple-negative breast cancer with residual disease after carboplatin-containing neoadjuvant chemotherapy.

Grazielle Morais Tavares et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.